{"id_": "1330839219611324416", "raw_data": {"created_at": "Mon Nov 23 11:42:50 +0000 2020", "id": 1330839219611324416, "id_str": "1330839219611324416", "full_text": "Hoffnungen auf eine schnelle Zulassung des Corona-Impfstoffes sind groß, die Chancen auf eine faire Verteilung hingegen gering. Denn die Interessen der Pharma-Monopole verhindern, dass alle Länder gut versorgt werden. https://t.co/h1NoNQ1z3Z", "truncated": false, "display_text_range": [0, 241], "entities": {"hashtags": [], "symbols": [], "user_mentions": [], "urls": [{"url": "https://t.co/h1NoNQ1z3Z", "expanded_url": "https://jacobin.de/artikel/covid-19-corona-impfstoff-zulassung-versorung-verteilung-pfizer-biontech-moderna/", "display_url": "jacobin.de/artikel/covid-…", "indices": [218, 241]}]}, "source": "<a href=\"https://mobile.twitter.com\" rel=\"nofollow\">Twitter Web App</a>", "in_reply_to_status_id": null, "in_reply_to_status_id_str": null, "in_reply_to_user_id": null, "in_reply_to_user_id_str": null, "in_reply_to_screen_name": null, "user_id": 915971477819854849, "user_id_str": "915971477819854849", "geo": null, "coordinates": null, "place": null, "contributors": null, "is_quote_status": false, "retweet_count": 2, "favorite_count": 10, "reply_count": 4, "quote_count": 4, "conversation_id": 1330839219611324416, "conversation_id_str": "1330839219611324416", "favorited": false, "retweeted": false, "possibly_sensitive": false, "possibly_sensitive_editable": true, "card": {"name": "summary_large_image", "url": "https://t.co/h1NoNQ1z3Z", "card_type_url": "http://card-type-url-is-deprecated.invalid", "binding_values": {"vanity_url": {"type": "STRING", "string_value": "jacobin.de", "scribe_key": "vanity_url"}, "domain": {"type": "STRING", "string_value": "jacobin.de"}, "title": {"type": "STRING", "string_value": "Der Corona-Impfstoff muss für alle zugänglich sein"}, "description": {"type": "STRING", "string_value": "Hoffnungen auf eine schnelle Zulassung des Corona-Impfstoffes sind groß, die Chancen auf eine faire Verteilung hingegen gering. Denn die Interessen der Pharma-Monopole verhindern, dass alle Länder..."}, "card_url": {"type": "STRING", "string_value": "https://t.co/h1NoNQ1z3Z", "scribe_key": "card_url"}}, "card_platform": {"platform": {"device": {"name": "Swift", "version": "12"}, "audience": {"name": "production", "bucket": null}}}}, "lang": "de", "supplemental_language": null}}